2023 - 2024 LEGISLATURE
LRB-2019/1
CMH:klm
2023 ASSEMBLY JOINT RESOLUTION 13
March 6, 2023 - Introduced by Representatives SINICKI, CABRERA, BALDEH, CONLEY,
DRAKE, EDMING, EMERSON, JACOBSON, JOERS, MOORE OMOKUNDE, MURPHY,
ORTIZ-VELEZ, OHNSTAD, PALMERI, SHANKLAND, SHELTON and SUBECK,
cosponsored by Senators COWLES, HESSELBEIN, JACQUE, LARSON and SPREITZER.
Referred to Committee on Rules.
1 Relating to: designating June 2023 as Myasthenia Gravis Awareness Month.
2 Whereas, myasthenia gravis (MG) is an autoimmune neuromuscular disease
3 that causes chronic weakness, in which antibodies attack receptors in the body and
4 prevent muscle contraction; and
5 Whereas, MG frequently weakens muscles that control eye movement, facial
6 expressions, and swallowing, and its symptoms may include blurred vision, speech
7 impairment, difficulty chewing, shortness of breath, an unstable gait, and a
8 weakened grip; and
9 Whereas, a diagnosis of MG may be missed or delayed because it shares
10 symptoms in common with many other disorders; and
11 Whereas, in some cases, MG symptoms can worsen to the point of disability,
12 grave illness, or death, if there are gaps in or an absence of the several crucial health
13 care treatments that can enable those who endure MG to lead productive, active lives
14 of normal longevity; and
 LRB-2019/1
2023 - 2024 Legislature -2- CMH:klm
1 Whereas, MG is found most commonly in adult women under 40 and men over
2 60, but is not specific to either gender or any particular ethnic background; and
3 Whereas, MG is nonhereditary and noncontagious; and
4 Whereas, 10 to 20 out of every 100,000 Americans are diagnosed with MG, and
5 support groups exist in Wisconsin for those people; now, therefore, be it
6 Resolved by the assembly, the senate concurring, That June 2023 is
7 hereby designated Myasthenia Gravis Awareness Month in Wisconsin.
8 (END)